Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). An extended release (“ER”) opioid in legitimate pain management generally accompanies an IR opioid, with patients taking the ER opioid on a set schedule and the IR opioid as needed. Several weeks later, also based on ability to pay, the U.S. Complaint ¶ 64.
139 
Let's personalize your content